Study of Primary Biliary Cholangitis and Its Progression
Part of Digestive system clinical trials.
This study observes people with primary biliary cholangitis (PBC) to learn more about the disease and what factors might make it worse over time. It uses your medical history and liver biopsy results to understand how PBC progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary biliary cholangitis (PBC) based on current guidelines.
- You have had a liver biopsy with a complete report available.
- Your medical records are mostly complete (less than 20% of key information missing).
- You do not have another liver disease, like hepatitis B or C, fatty liver, or alcoholic liver disease.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with primary biliary cholangitis (a long-term liver and bile duct condition). It may help doctors better understand the disease in different people, including those identified by specific blood antibody tests.
This study tracks patients with primary biliary cholangitis (PBC) over time to understand long-term outcomes. It aims to gather information that could improve care and management for people with PBC.
This trial looks at whether slowly reducing UDCA (a medication for primary biliary cholangitis) is safe and still helpful in people whose liver tests have improved. It may help some patients avoid higher doses if their disease is well controlled.
This research study tracks how well Primary Biliary Cholangitis (PBC) responds to standard medication (UDCA) and what happens to patients' health over time. It may help doctors understand which treatments work best for different people.
This is a registry study that collects health information from people with primary biliary cholangitis (PBC), a rare liver disease where the immune system damages bile ducts. By joining, you help researchers better understand PBC and improve care for patients with this condition.
This study collects and stores samples from people with PSC (primary sclerosing cholangitis), PBC (primary biliary cholangitis), and some related liver conditions. Researchers use these samples to better understand these diseases and support future research.
Hear when a new PBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.